The carbon footprint of as-needed budesonide-formoterol in mild asthma: a post hoc analysis.
Lee HatterMark HollidayAllie EathornePepa BruceIan D PavordHelen K ReddelRobert J HancoxAlberto PapiMark WeatherallRichard BeasleyPublished in: The European respiratory journal (2024)
The as-needed budesonide-formoterol DPI treatment option was associated with a markedly lower carbon footprint than as-needed salbutamol pMDI and maintenance budesonide DPI plus as-needed salbutamol pMDI.